INC Research Holdings, Inc. (INCR) stock prices updated...
 

INC Research Holdings, Inc. stock price

INC Research Holdings, Inc. latest news:


  • 08/18/2017 11:41:05

    Gold prices fail to hold above key $1,300 level

    Gold prices touched their highest intraday level of the year on Friday, briefly topping $1,300 an ounce before pulling back to settle lower for the session. "The selloff is unusual as there was no data or market news to account for the [roughly] $15 drop" from the day's highs, said Mark O'Byrne, research director at GoldCore. "Risk aversion has eased with stocks eking out small gains and some traders may have decided to take profits at the $1,300 level." December gold fell 80 cents, or less than 0.1%, to settle at $1,291.60 an ounce after trading as high as $1,306.90. For the week, it fell 0.2%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 08/17/2017 15:35:24

    Lockheed Martin awarded part of $499 million U.S. defense contract: Pentagon

    WASHINGTON (Reuters) - Top U.S. defense contractor Lockheed Martin was named on Thursday as one of six companies that will share a $499 million contract for research into aerospace systems aimed at developing new technologies and capabilities, the Pentagon said.

  • 08/16/2017 22:26:00

    Cancer centers accused of Medicare fraud, unsafe practices

    Florida Cancer Specialists & Research Institute and 21st Century Oncology accused of gender bias, fraudulent Medicare billing and unsafe practices        

  • 08/15/2017 14:46:09

    BRIEF-Bellicum Pharmaceuticals enters a cancer research grant contract with cancer prevention and research institute of Texas

    * Bellicum Pharmaceuticals says ‍on Aug. 9, entered a cancer research grant contract with cancer prevention and research institute of Texas

  • 08/15/2017 13:01:00

    Can We Feed The World With Farmed Fish?

    New research suggests there is space on the open ocean to farm essentially all the seafood humans can eat — and then some. But such volumes of fish and shellfish could not be grown without costs.

  • 08/14/2017 15:26:44

    Tepper's Appaloosa dumps Snap Inc., stake, loads up on tech, health care

    David Tepper's hedge fund Appaloosa Management unloaded its position in Snapchat-parent Snap Inc., and disclosed increases in the tech and health-care sectors at the end of the second quarter. As of June 30, Tepper's fund showed that his fund dumped 100,000 shares of of Snap Inc. , which has lost more than a third of its value since it debuted as a public entity in early March. Tepper had been one of a number of prominent investors who had vocally expressed support of the social-messaging company. On Monday, Snap's shares were among the most active, gaining about 6.5% to start the week. Elsewhere, Appaloosa showed new positions in the PowerShares QQQ Trust Series 1 , which mimics the technology laden Nasdaq-100 , purchasing 1.8 million shares of the so-called QQQs, valued at $249 million, representing about 3.7% of his overall portfolio, according to data from research provider Whalewisdom.com. The fund also more than doubled its Apple Inc. position to 625,000 shares worth about $90 million and those of Altaba Inc. , which he boosted to 5.1 million shares valued at $280 million. Appaloosa showed a fresh stake in Alibaba Group Holding Limited , scooping up 3.6 million shares worth $520 million. Tepper's investment vehicle added a new position in exchange-traded IBB , a prominent ETF tracking the biotech sector, and SPDR S&P Biotech ETF , which closely mimics the S&P 500's health-care sector. Tepper's firm bought 235,000 shares of IBB worth about $73 million and 330,000 shares of XBI valued at $34 million, as of the end of June. In other sales, Tepper & Co. unloaded all of its position in Teva Pharmaceutical Industries , Energy Transfer Partners L.P. and Pfizer Inc. among others. Related: Active-managers have a new favorite toolMarket Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 08/14/2017 15:14:19

    Tepper's Appaloosa dumps Snap Inc. stake, loads up on tech, health care

    David Tepper's hedge fund Appaloosa Management unloaded its position in Snapchat-parent Snap Inc., and disclosed increases in the tech and health-care sectors at the end of the second quarter. As of June 30, Tepper's fund showed that his fund dumped 100,000 shares of of Snap Inc. , which has lost more than a third of its value since it debuted as a public entity in early March. Tepper had been one of a number of prominent investors who had vocally expressed support of the social-messaging company. On Monday, Snap's shares were among the most active, gaining about 6.5% to start the week. Elsewhere, Appaloosa showed new positions in the PowerShares QQQ Trust Series 1 , which mimics the technology laden Nasdaq-100 , purchasing 1.8 million shares of the so-called QQQs, valued at $249 million, representing about 3.7% of his overall portfolio, according to data from research provider Whalewisdom.com. The fund also more than doubled its Apple Inc. position to 625,000 shares worth about $90 million and those of Altaba Inc. , which he boosted to 5.1 million shares valued at $280 million. Appaloosa showed a fresh stake in Alibaba Group Holding Limited , scooping up 3.6 million shares worth $520 million. Tepper's investment vehicle added a new position in exchange-traded IBB , a prominent ETF tracking the biotech sector, and SPDR S&P Biotech ETF , which closely mimics the S&P 500's health-care sector. Tepper's firm bought 235,000 shares of IBB worth about $73 million and 330,000 shares of XBI valued at $34 million, as of the end of June. In other sales, Tepper & Co. unloaded all of its position in Teva Pharmaceutical Industries , Energy Transfer Partners L.P. and Pfizer Inc. among others.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 08/14/2017 01:59:04

    Tesla price target lifted to $411 at Baird who says don't short ahead of Model 3

    Tesla Inc.'s price target was lifted to $411 per share from $368 on Monday by Baird, whose analysts advised against shorting shares of the company ahead of the Model 3 production ramp. Reiterating an outperform rating on the electric-car maker, senior research analyst Ben Kallo had this to say: "In our our opinion, TSLA is not a good short headed into the Model 3 ramp as we continue to believe upcoming catalysts will drive shares higher, and TSLA remains a top pick for 2017." He said they expect "strong demand" for Tesla's mass-market Model 3, whose production ramp up is expected this fall, and that stock performance following its introduction could mirror that of which was seen for the Model S. "Importantly, a positive reception to the Model 3 from early customers could significantly increase the value of the Tesla Brand and further accelerate demand," said Kallo. Tesla shares closed up 0.7% on Friday to $357.87.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 08/11/2017 09:21:07

    JP Morgan Asset Management says will absorb research costs due to MiFID-II

    LONDON (Reuters) - JP Morgan Asset Management said on Friday that it will absorb the cost of paying brokers for investment research rather than pass it on to its clients when new European regulation comes in next year.

  • 08/10/2017 16:12:02

    U.S. stock funds post largest withdrawals in 5 weeks -Lipper

    U.S. fund investors peeled back their exposure to stocks and bought bonds during the latest week, Lipper data showed on Thursday, as saber-rattling between the United States and North Korea appeared to shake investor sentiment. Stock funds in the United States posted $2.8 billion in withdrawals during the latest week, marking the largest outflows in five weeks, according to the research service.

  • 08/10/2017 09:53:58

    MOVES-Duff & Phelps hires analyst to cover global utilities

    Aug 10 (Reuters) - Duff & Phelps Investment Management Co, an affiliated manager of Virtus Investment Partners Inc appointed Benjamin Bielawski as senior research analyst to cover global utilities.

  • 08/10/2017 09:39:02

    ADP CEO slams Ackman's research and 'spoiled brat' antics

    NEW YORK (Reuters) - The CEO of Automatic Data Processing Inc slammed investor William Ackman on Thursday, likening the hedge fund manager to a "spoiled brat" and skewering the billionaire's research efforts into the payroll processor.

  • 08/08/2017 17:26:37

    Economic Scene: The Danger From Low-Skilled Immigrants: Not Having Them

    A wealth of research shows that the economy is lifted by foreign workers, providing new opportunities for the native-born.

  • 08/08/2017 14:18:01

    BRIEF-Prothena reports Q2 loss per share $0.46

    * Prothena reports second quarter 2017 financial results and provides research and development update

  • 08/07/2017 11:20:27

    Funds target 'unknown' stocks as Wall Street cuts analyst jobs

    NEW YORK (Reuters) - With a nearly 30-percent gain in 2017, shares of industrial products maker Handy & Harman Ltd are outpacing hot stocks like Google-parent Alphabet Inc and Visa Inc . Yet few on Wall Street have ever heard of the $412-million market-cap company, in large part because no sell-side research analysts publish any estimates of its earnings.

  • 08/07/2017 05:23:55

    iPhone maker Foxconn plans another multibillion-dollar plant -- this time in Michigan

    Foxconn Technology Co. , the Taiwan-based maker of Apple Inc.'s iPhones, said it plans to open a multibillion-dollar plant in Michigan, according to a report from the South China Morning Post. The news comes just a week after the company said it would invest up to $10 billion plant in Wisconsin. Foxconn's Michigan plant will be used for the research and development of autonomous vehicles, according to the South China Morning Post, citing Foxconn founder Terry Gou. The amount of the investment and other details have not yet been disclosed. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 08/06/2017 17:09:48

    'Huge gap' in living standards for ethnic groups

    Bangladesh, Pakistani and Black African families earn less than white households, research suggests.

  • 08/04/2017 14:34:57

    BRIEF-Dyadic concludes research services agreement with Dupont

    * Dyadic announces the conclusion of its research services agreement with Dupont

  • 08/03/2017 14:57:06

    BRIEF-Vital Therapies Q2 loss per share $0.29

    Vital Therapies Inc(VTL): * Vital Therapies(VTL) announces second quarter 2017 financial results. * Q2 loss per share $0.29. * Q2 earnings per share view $-0.35 -- Thomson Reuters I/B/E/S. * Vital Therapies Inc (VTL) - research and development expenses increased to $9.8 million for three months ended June 30 versus $6.9 million for 3 months ended June 30, 2016​ Source text for Eikon: Further company coverage:

  • 08/01/2017 18:36:35

    Monsanto’s Sway Over Research Is Seen in Disclosed Emails

    Documents released in a lawsuit against the company raised new questions about its efforts to influence the news media and scientific research.

  • 07/31/2017 14:09:07

    Snap shares end session down 1% despite lockup expiration

    Shares of Snap Inc. ended the session down just 1% from Friday's close, despite a lockup expiration. Though shares reached a record intraday low of $13.10 Monday, they rallied back to close at $13.68. Analysts had been concerned that insiders and investors would sell their shares Monday, as they looked for liquidity and as Snap has had a bumpy path since its IPO. Analysts estimated close to one billion shares could be available to sell. Still, investors were well aware of the lockup and CFRA Research said Monday that they believed close to half of the shares were held by executive officers and directors who were unlikely to sell. But other shares could still be sold. Shares of Snap have fallen 23% in the past month, while the S&P 500 has gained 2%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 07/31/2017 09:07:58

    British consumers grappling with heavier debt loads: Moody's

    British households are increasingly grappling with debt at a time the U.K. economy is showing signs of slowing, Moody's Investors Service warned Monday. "Household debt is high and still growing, leaving consumers vulnerable to an economic downturn, while higher inflation, weaker wage growth and levels of indebtedness leaves those in lower-income brackets the most exposed," wrote Greg Davies, a research analyst at Moody's. Delinquencies and charge-offs for credit card asset-backed securities, in particular, should increase if unemployment rises, Moody's said in a note outlining its downgraded outlook for four out of five U.K. consumer-structured finance sectors. However, "we have maintained the stable outlook on U.K. prime [residential mortgage-backed securities] because this mortgage market is robust, with borrowers that have strong repayment capacity and have benefited the most from the recent decline in the interest rates", said Davies. Moody's warning came separately from June credit data from the Bank of England showing total borrowing surpassed £200 billion ($236 billion). Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 07/28/2017 11:07:22

    Wealth Matters: Private Equity-Like Fund Aims to Speed Up Diabetes Research

    The goal of the T1D Fund, which received $32 million in seed funding from the Juvenile Diabetes Research Foundation, is to speed new products to market.

  • 07/28/2017 09:04:38

    Zacks Industry Outlook Highlights: Comcast, AT&T, Verizon Communications, Charter Communications and Sprint

    For Immediate Release Chicago IL July 28 2017 Today Zacks Equity Research discusses the Industry Telecom Part 1 including Comcast Corp NASDAQ CMCSA Free Report AT amp T Inc NYSE T Free Report Verizon Communications Inc NYSE VZ Free Report

  • 07/28/2017 06:44:28

    Merck expects June cyberattack to affect company's 2017 financial performance

    Merck & Co. Inc. said Friday that a network cyberattack in late June caused it to issue conservative 2017 guidance. The June 27 cyberattack disrupted the company's global operations, including manufacturing, research and sales, and Merck said it has been working to restore operations. Merck said it "does not yet know the magnitude of the impact of the disruption," but that guidance would have been higher if not for the cyberattack's impact. Merck said it can continue to supply its top products, including cancer drug Keytruda and diabetes drug Januvia, but there will be temporary delays in some other products in certain markets. Merck, which reported second-quarter profit and revenue beats on Friday, also affirmed its 2017 adjusted EPS outlook of $3.76 to $3.88, with Chief Financial Officer Robert Davis saying that "the strength of the business has allowed us to absorb the potential impact from the cyber attack," according to the FactSet earnings call transcript. Merck was one of several global companies hit by massive cyberattacks in late June. Merck shares lifted 0.4% in premarket trade Friday. Shares surged 2.2% over the last three months, compared with a 3.8% rise in the S&P 500 .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 07/26/2017 17:37:45

    BRIEF-Astellas announces wind-down of Agensys research operations

    * Astellas announces wind-down of Agensys research operations

  • 07/26/2017 14:38:26

    REFILE-UPDATE 3-GlaxoSmithKline's new boss streamlines R&D, axes slew of drugs

    LONDON, July 26 (Reuters) - GlaxoSmithKline's new chief executive announced plans on Wednesday to narrow the focus of the group's drug research by ditching more than 30 drug projects to improve returns in its core pharmaceuticals business.

  • 07/26/2017 09:16:51

    More evidence that owning a dog is really good for you

    Dogs are more than just cuddly companions — research continues to show that pets bring real health benefits to their owners        

  • 07/25/2017 17:51:32

    BRIEF-Amazon says to double research and development roles in London

    * Amazon announces plans to double research and development roles in london as it opens new uk head office

  • 07/25/2017 13:25:05

    Dick's Sporting Goods downgraded on concerns about e-commerce shift

    Dick's Sporting Goods Inc. was downgraded to peer perform at Wolfe Research on Tuesday based on concerns about the shift to e-commerce from bricks-and-mortar retail. "Given the challenging reads through the first half of 2017, we believe any share gain potential will largely be eroded away by current oversupply, with too many goods chasing too little demand," analysts led by Adrienne Yih wrote. There's also "limited evidence" that Dick's is snapping up market share from competitors that are leaving the sector, the note said. "We believe Dick's is susceptible to severe deleverage and leaves us skeptical of further store openings beyond the current outlined plans," the note said, with Yih adding that Dick's is "sacrificing gross margin for comp" in an effort to price competitively. Dick's shares are up 1.6% in Tuesday trading, but down nearly 33% for the year so far. The S&P 500 index is up 10.7% for 2017 to date.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • More trends:

    inContact, Inc.SAAS | Incyte CorporationINCY | Independent Bank Corp.INDB | Independent Bank CorporationIBCP | Independent Bank Group, IncIBTX | Industrial Services of America, Inc.IDSA | Infinera CorporationINFN | Infinity Pharmaceuticals, Inc.INFI | Infinity Property and Casualty CorporationIPCC | Information Services Group, Inc.III |